MOUNJARO 2.5 MG

$1,200.00 $1,450.00

Mounjaro, developed by Eli Lilly, is a once-weekly injectable treatment containing the active ingredient tirzepatide, designed to support weight loss. It works by helping you feel fuller for longer and reducing appetite, making it easier to manage food intake. Mounjaro is approved and licensed for weight loss in the US-UK and is available by prescription.

The pack includes:

  • • Each dose (0.6 ml) contains 2.5 mg of tirzepatide.

Mounjaro mimics hormones that naturally occur in the gut after eating, called incretins. Incretins have many functions, such as:

  • • slowing down the emptying of the stomach

  • • sending signals to your brain that you’re full after eating

  • • increasing insulin levels

These combined effects help people feel full after a meal by signalling to the parts of the brain responsible for appetite, making it easier to eat less.

THE ORIGIN OF THIS PRODUCT IS FROM THE United States COMMUNITY

Mounjaro, developed by Eli Lilly, is a once-weekly injectable treatment containing the active ingredient tirzepatide, designed to support weight loss. It works by helping you feel fuller for longer and reducing appetite, making it easier to manage food intake. Mounjaro is approved and licensed for weight loss in the US-UK and is available by prescription.

The pack includes:

  • • Each dose (0.6 ml) contains 2.5 mg of tirzepatide.

Mounjaro mimics hormones that naturally occur in the gut after eating, called incretins. Incretins have many functions, such as:

  • • slowing down the emptying of the stomach

  • • sending signals to your brain that you’re full after eating

  • • increasing insulin levels

These combined effects help people feel full after a meal by signalling to the parts of the brain responsible for appetite, making it easier to eat less.

THE ORIGIN OF THIS PRODUCT IS FROM THE United States COMMUNITY